Inventor

Toru Sasaki

Inventor
Fukushima, JP

Overview

19→
Patents
1992–2020
Patent span
Chemistry
Primary field (CPC C)

Patents· 19 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C12Pprimary
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture14%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations12%
C07CAcyclic or carbocyclic compounds12%
C07DHeterocyclic compounds12%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium9%
C07KPeptides7%
A61KPreparations for medical, dental or toiletry purposes5%
C12NMicroorganisms or enzymes5%
Y02PClimate change mitigation technologies in the production or processing of goods5%
A01NPreservation of bodies of humans or animals or plants or parts thereof2%
PatentTitleYear
10,745,692Production method for charged non-protein amino acid-containing peptide202010,711,268Method for producing peptide library, peptide library, and screening method20209,045,525'Amyloid β-protein-specific production-inhibiting polypeptide'20157,579,066'Ethylenically unsaturated group-containing isocyanate compound and process for producing the same, and reactive monomer, reactive (meth) acrylate polymer and its use'20097,569,718'Production process of fluorinated benzonitrile'20097,132,561'Process for producing fluorinated dicyanobenzene'20066,624,336'Process for producing tetrafluorobenzenemethanols'20036,432,978'SF2809-I,II,III,IV,V and VI substances exhibiting chymase-inhibiting activities'20026,171,829'Physiologically active substance PF1191 and process for producing the same'20015,914,348'Substance FA-70D, process for producing the same, and uses thereof'19995,859,289'Method for isolating N-phosphonomethylglycine'19995,817,816'Sesquiterpene derivatives having progesterone receptor binding inhibitory activity'19985,750,774'Method for producing N-phosphonomethylglycine'19985,698,528'Substance IT-62-B and medicinal composition containing the same'19975,679,844'Manufacturing method for phosphonic acid derivatives'19975,324,855'Preparation of N-acylaminomethylphosphonic acid'19945,194,617'2,3-disubstituted-4-hydroxyquinoline derivatives'19935,164,507'Antibiotic pyridine compound'19925,116,815'PF 1022 substance, method of treating helminthic parasitic infection and anthelmintic composition'1992

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1992–2002Patents assigned to MEIJI SEIKA KAISHA (6)· patent assignee history
1992–2001Based in Kanagawa, JP· patent location history
1993–2002Based in Yokohama, JP· patent location history
1994–2009Patents assigned to SHOWA DENKO KK (8)· patent assignee history
1997–1999Patents assigned to TAIHO PHARMACEUTICAL CO LTD (2)· patent assignee history
1997–1999Based in Tokushima, JP· patent location history
1998–2009Based in Fukushima, JP· patent location history
2015–2020Based in Tokyo, JP· patent location history
2020Patents assigned to PEPTIDREAM INC (2)· patent assignee history
2020Patents assigned to UNIV TOKYO (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SHOWA DENKO KK81994–2009
MEIJI SEIKA KAISHA61992–2002
PEPTIDREAM INC22020
TAIHO PHARMACEUTICAL CO LTD21997–1999
UNIV TOKYO22020
Locations
LocationPatentsSpan
Fukushima, JP51998–2009
Tokyo, JP32015–2020
Yokohama, JP31993–2002
Kanagawa, JP31992–2001
Tokushima, JP21997–1999